Nationwide survey on complementary and alternative medicine in cancer patients in Japan
about
The use of Complementary and Alternative Medicine by cancer patientsThe translational aspect of complementary and alternative medicine for cancer with particular emphasis on KampoReduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapyPatterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan.Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group.Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey.A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer.Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.Soliciting an herbal medicine and supplement use history at hospice admissionECA39 is a novel distant metastasis-related biomarker in colorectal cancerComplementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionalsUsing Basic Science to Develop an Innovative Program in Complementary and Alternative MedicineComplementary and alternative medicine use by visitors to rural Japanese family medicine clinics: results from the international complementary and alternative medicine survey.The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patientsThe clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional surveyInappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan.Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements.Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission.Use of Chinese medicine by cancer patients: a review of surveys.Concomitant use of dietary supplements and medicines in patients due to miscommunication with physicians in Japan.Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label StudyDrug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan.Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in GermanyProgressive muscle relaxation as a supportive intervention for cancer patients undergoing chemotherapy: A systematic review.Consultation clinics for complementary and alternative medicine at Japanese university hospitals: An analysis at Tokushima University HospitalUse of chinese herb medicine in cancer patients: a survey in southwestern china.Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey.Use of complementary and alternative medicine by patients with hematological diseases experience at a university hospital in northeast MexicoUtilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and PhysiciansCancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.First nationwide attitude survey of Japanese physicians on the use of traditional Japanese medicine (kampo) in cancer treatment.Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea.Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology.Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.Complementary and alternative medicine usage in cancer patients in southeast of Turkey
P2860
Q24683698-BA7EE7BF-4997-4E27-BEBB-167EBC4B1E66Q26795520-4AF2B49F-39DB-41E7-B4FC-0774591B5824Q28235605-BBD46622-9792-491C-BE0E-6E4846F60AA0Q33330471-02CFA807-8BE2-45AC-80AB-A8D366819899Q33559486-62283F98-D13C-4179-B4E2-2896FAE65C77Q33587343-D9E423B7-EFFC-48E7-9FA8-3D728C66A33EQ33626012-3A181369-2E43-456C-AB2E-FEC144A6A1DCQ33648514-1A3318CF-F288-4369-9AA9-B92B08B2386FQ33732930-F3119D58-4C8B-4771-A645-1314244CBD92Q33733423-01F3B487-3C74-4A26-9CA3-BEC9ECA4F766Q33751861-1547B9F2-4190-4822-953C-E334E222B070Q33909844-81713551-C0AA-4A2C-A90E-C1042E746BB0Q33910457-8AFA8503-450F-4F85-B7C6-604F6CE9F09CQ34159526-3801D4F1-5BBB-49EF-964E-493F8744BDA7Q34318399-4EDEB825-B932-46D3-9437-7C11D792220CQ34331575-A7BFDC6F-7BEC-49F3-A238-8272755F85D1Q34402006-48C44886-9336-4924-83F4-45DFD2BE6065Q34483395-0F9B3831-BA7A-4613-8B66-1F09FEC1BE22Q34774934-70BAFDC1-2099-4F9A-B96C-D16BE12521BAQ34969344-F9377679-48E5-4EE6-832C-75FFFEB02150Q34974336-4A5F9CBF-F557-4305-9450-6F8B65017443Q35141095-EDD9C124-3BEB-477A-9BDF-8529B328A72CQ35586021-2C09B783-9594-4213-A554-051D4F9D8EA5Q35609786-F7A4FB34-CA25-4E02-84D6-DA195F8CE112Q36070432-84796F19-8271-492E-BBD4-77E77C0AFDD6Q36180815-0B8ED45E-E6B9-4DBA-BB4A-34EDDEE31926Q36182230-DA035EBF-9864-4051-AD4B-5F785732278AQ36204792-D9E81A1A-262A-40AD-B26E-4E6F25873E10Q36244252-CF819400-6C05-406E-BF26-2A5E4C5BF54AQ36246975-57F05B33-BE08-4C5A-8433-59F5B8D480BDQ36254532-65D17E8B-B53E-481D-A67A-E8BB31B16845Q36283131-9587E95C-6B82-4429-A0D7-C47567ACA020Q36329995-0586399B-E2CD-4B4D-8663-97470C52DFEAQ36405687-7018697A-95F0-4DC1-BCA0-8C0CEAD36629Q36477176-22D755EF-7C66-43DB-86FE-23EDEB165CA3Q36531132-860DC9ED-59BA-4BE5-A444-1DD62B7F2F1AQ36764216-AC421E30-8718-46D8-AA8C-364FA1255A56Q36865004-E1603027-7E17-40CC-A1BF-EAD2CBAD3996Q37056096-E79FCBBC-A460-4A3A-8833-C55ABD55F84AQ37102409-B6DD0641-0831-4469-99E7-C5A0D3380CCA
P2860
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@ast
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@en
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@nl
type
label
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@ast
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@en
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@nl
prefLabel
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@ast
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@en
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@nl
P2093
P3181
P356
P1476
Nationwide survey on complementary and alternative medicine in cancer patients in Japan
@en
P2093
Ichinosuke Hyodo
Jiro Imanishi
Kenji Eguchi
Masaru Narabayashi
Midori Hirai
Noriko Amano
Shigemitsu Takashima
Tomohito Nakano
P304
P3181
P356
10.1200/JCO.2005.04.126
P407
P577
2005-04-20T00:00:00Z